-
1
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review an...
Published 2024-12-01Subjects: “…Cardiovascular-related events…”
Get full text
Article